Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3001334	s-ancak	— (—)	247	259	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Acute renal failure

15.81

64.02

1.1

—

Bacterial infection, other or unspecified

9.81

63.58

1.1

1.0

—

Dialysis, with operation codes

23.20

63.51

1.0

1.1

—

Renal failure

9.17

63.35

1.1

—

ILD medications: immunosuppressive drugs

8.70

60.05

1.1

1.0

—

Other bacterial diseases

109

112

6.74

59.10

1.1

1.0

—

Nephropathy related operations

21.14

58.50

1.0

—

Renal tubulo-interstitial diseases

104

121

6.60

58.17

1.0

—

Chronic kidney disease

11.45

53.00

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

109

100

6.17

49.59

1.1

1.0

—

Pneumonia, organism unspecified

113

6.02

47.20

1.1

1.0

—

Influenza and pneumonia

105

125

5.53

46.55

1.1

1.0

—

Implicit Sepsis

101

6.47

46.54

1.1

1.0

—

Implicit bacterial Sepsis

9.04

46.34

1.1

1.0

—

ILD medications

108

103

5.76

45.65

1.1

1.0

—

Bacterial Sepsis

8.26

45.56

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

101

128

5.47

45.37

1.1

1.0

—

All pneumoniae

101

128

5.45

45.13

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

100

6.02

45.10

1.1

1.0

—

100

6.02

45.10

1.1

1.0

—

Septicaemia

9.14

44.58

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

128

5.44

44.50

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

111

5.70

41.57

1.1

—

First line medication for Crohn's disease

102

103

5.41

40.58

1.1

1.0

—

Oral corticosteroids

102

121

5.11

40.29

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

137

5.03

40.13

1.0

1.1

—

Explicit Sepsis

7.69

39.54

1.1

1.0

—

Fever of other and unknown origin

6.68

39.38

1.1

1.0

—

Other septicaemia

8.63

39.16

1.0

—

Systemic connective tissue disorders

7.93

39.12

1.1

1.0

—

Other necrotizing vasculopathies

23.57

38.68

1.1

—

Inflammatory bowel disease treatment related agents

102

124

4.68

35.78

1.1

1.0

—

Other necrotizing vasculopathies (FG)

24.24

33.42

1.1

1.0

—

Care involving dialysis

23.17

31.48

1.1

1.0

—

Glomerular diseases

9.77

31.18

1.1

—

L04AD Calcineurin inhibitors

14.53

28.78

1.1

1.0

—

Heart failure, not strict

107

4.64

27.28

1.1

—

L04AA Selective immunosuppressants

7.85

26.36

1.1

1.0

—

Extracorporeal dialysis

20.17

25.80

1.1

1.0

—

Heart failure,strict

5.32

25.05

1.1

—

Glomerular disorders in diseases classified elsewhere

11.42

24.01

1.0

—

Unspecified kidney failure

15.08

23.64

1.0

1.1

—

Autoimmune diseases related-to ILD

160

3.74

21.41

1.1

1.0

—

Transplanted organ and tissue status

11.64

21.34

1.0

1.1

—

Bacterial pneumoniae

6.12

21.25

1.1

1.0

—

Bacterial pneumonia, not elsewhere classified

5.96

20.17

1.1

1.0

—

Polyarthropathies

104

4.04

20.07

1.1

1.0

—

Certain infectious and parasitic diseases

4.12

20.02

1.1

1.0

—

Other respiratory diseases principally affecting the interstitium

7.97

20.00

1.1

1.0

—

ILD, hospital admission 2, with pulmonary infections

11.82

19.58

1.1

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

13.55

19.51

1.1

1.0

—

L04AX Other immunosuppressants

118

4.24

19.39

1.1

1.0

—

Heart failure, strict

4.20

19.29

1.1

—

Reimbursement for rheumatic diseases

120

4.16

18.91

1.0

1.1

—

Heart failure and antihypertensive medication

8.72

18.77

1.0

1.1

—

ILD medications: azathioprine

11.90

18.68

1.3

1.0

—

Azathioprine

11.90

18.68

1.3

1.0

—

Ulcer of lower limb, not elsewhere classified

8.88

18.53

1.1

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

10.59

18.22

1.1

1.0

—

Second line medication for Crohn's disease

124

4.04

18.18

1.1

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

9.10

17.85

1.0

1.1

—

Gout

5.85

17.32

1.0

1.1

—

COPD/asthma related infections

100

3.56

17.21

1.1

1.0

—

COPD/asthma/ILD related infections

100

3.56

17.21

1.1

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

4.99

16.82

1.0

—

Dyspnoea

154

3.28

16.56

1.1

1.0

—

Continuous positive airway pressure

7.45

16.45

1.1

1.0

—

Diseases of arteries, arterioles and capillaries

107

3.77

16.41

1.0

1.1

—

Gout, FINNGEN

5.34

16.33

1.0

1.1

—

Persons encountering health services for specific procedures and health care

149

3.12

16.26

1.0

1.1

—

All-cause Heart Failure

3.87

15.89

1.0

1.1

—

ILD, hospital admissions

7.61

15.68

1.1

1.0

—

Bacterial pneumonia (organism specified)

4.16

15.52

1.1

1.0

—

Anaemias

10.75

15.51

1.0

1.2

—

General symptoms and signs

114

3.21

15.36

1.1

1.0

—

Other interstitial pulmonary diseases

7.36

15.24

1.1

1.0

—

Interstitial lung disease

7.36

15.24

1.1

1.0

—

Interstitial lung disease endpoints

7.36

15.24

1.1

1.0

—

COPD (mode)

6.31

14.88

1.0

—

Glomerulonephritis

9.04

14.66

1.1

1.0

—

Other systemic involvement of connective tissue (FG)

5.88

14.62

1.1

1.0

—

Other heart diseases

5.57

14.51

1.0

1.1

—

ILD, hospital admissions 1, main diag only

7.72

14.41

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

134

3.00

14.17

1.1

1.0

—

Gout, idiopatic and unspecified

5.10

14.07

1.0

1.1

—

Other disorders of urethra and urinary system

108

3.47

13.62

1.0

—

Autoimmune diseases excluding thyroid diseases

137

2.92

13.58

1.1

1.0

—

Hypertensive diseases (excluding secondary)

5.33

13.56

1.0

1.1

—

Gout, unspecified

5.43

13.51

1.0

1.1

—

Acute tubulo-interstitial nephritis

3.75

13.13

1.0

1.1

—

Other systemic involvement of connective tissue

5.10

13.13

1.1

1.0

—

Finngen Rheumatological endpoints

115

3.07

12.87

1.1

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

136

3.27

12.72

1.1

1.0

—

Peripheral artery operations in Hilmo

7.05

12.68

1.0

—

Abnormalities of breathing

108

3.14

12.40

1.1

1.0

—

Haemorrhage from respiratory passages

4.64

12.38

1.1

1.0

—

Aplastic and other anaemias

3.64

11.92

1.0

1.1

—

Cardiomyopathy

5.85

11.78

1.0

1.1

—

DVT of lower extremities and pulmonary embolism

3.76

11.63

1.1

—

Gout, strict definition

5.24

11.52

1.0

1.1

—

Antihypertensive medication - note that there are other indications

4.28

11.51

1.0

1.1

—

Implicit viral Sepsis

6.68

11.45

1.0

—

Viral Sepsis

6.68

11.45

1.0

—

Erysipelas

3.83

11.34

1.1

1.0

—

Kidney transplant status

25.17

11.14

1.1

1.0

—

Malaise and fatigue

3.83

11.05

1.0

—

Polymyalgia rheumatica

7.29

10.98

1.1

1.0

—

Diabetic nephropathy, excluding more controls

6.85

10.87

1.1

—

Other diseases of pleura

107

3.32

10.74

1.1

1.0

—

Bleeding

146

2.79

10.71

1.1

1.0

—

Venous thromboembolism

122

3.19

10.33

1.1

1.0

—

Peripheral arterial reconstruction

5.13

10.29

1.0

1.1

—

Autoimmune diseases

137

2.57

10.23

1.1

1.0

—

Cardiomyopathies, Primary/intrinsic

6.68

10.17

1.1

—

Cardiomyopathy (excluding other)

6.68

10.17

1.1

—

Infections, IBD-co-morbidities

7.29

10.17

1.0

—

Abnormal findings on diagnostic imaging of lung

114

3.25

10.14

1.1

1.0

—

Other pulmonary diagnosis

3.32

10.07

1.0

—

Cerebrovascular diseases (FINNGEN)

5.97

10.05

1.1

1.0

—

Cardiovascular diseases

3.94

9.88

1.0

—

Infections of the skin and subcutaneous tissue

145

2.96

9.86

1.1

—

Nutritional anaemias

102

3.34

9.77

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

3.24

9.55

1.0

—

Iron deficiency anaemia

3.53

9.46

1.1

—

Heart failure and bmi 25plus

4.11

9.38

1.1

—

Dentinal caries

4.32

9.24

1.0

1.1

—

Later onset COPD, excluding more controls

5.86

9.21

1.1

1.0

—

Asthma, unspecified (mode), excluding more controls

4.27

9.19

1.1

1.0

—

Care involving use of rehabilitation procedures

128

2.97

9.17

1.0

1.1

—

Complications of procedures, not elsewhere classified

164

2.64

9.03

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

171

2.48

8.99

1.0

1.1

—

Asthma, excluding more controls

3.49

8.90

1.1

1.0

—

Enterocolitis due to Clostridium difficile

6.68

8.89

1.0

—

Rheumatoid arthritis

3.99

8.84

1.0

1.1

—

Pain in throat and chest

105

2.80

8.82

1.1

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

4.88

8.82

1.0

—

Other and unspecified iron deficiency

3.59

8.80

1.1

—

Other diseases of urinary system

135

2.50

8.75

1.0

1.1

—

Diabetic nephropathy

5.09

8.71

1.1

—

Streptococcal septicaemia

10.03

8.64

1.1

1.0

—

Used for control exclusion in common control thyroid runs

127

2.48

8.58

1.1

1.0

—

Peripheral artery disease

3.22

8.57

1.0

1.1

—

Atrial fibrillation and flutter

5.23

8.54

1.1

1.0

—

Paroxysmal tachycardia

6.35

8.53

1.0

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

3.56

8.37

1.1

—

Non-ischemic cardiomyopathy

4.02

8.33

1.0

1.1

—

GASTRO-related operations

2.90

8.25

1.0

—

Any gastric operation

2.90

8.25

1.0

—

Other and unspecified anaemias

3.23

8.23

1.0

1.1

—

Other anaemias

3.22

8.19

1.0

1.1

—

Asthma (only as main-diagnosis), excluding more controls

3.47

8.19

1.1

1.0

—

Other arthritis (FG)

4.20

8.18

1.1

1.0

—

Other acute lower respiratory infections

122

2.90

8.17

1.2

1.0

—

Methotrexate

7.07

7.99

1.1

1.0

—

Hypertensive diseases

2.80

7.95

1.0

1.1

—

Hypertension

2.80

7.95

1.0

1.1

—

Asthma-related pneumonia

3.33

7.89

1.1

1.0

—

COPD differential diagnosis

2.98

7.87

1.0

—

ILD differential diagnosis

2.98

7.87

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

3.16

7.83

1.0

1.1

—

Dental caries

3.80

7.83

1.0

1.1

—

Pulmonary embolism

3.58

7.82

1.1

—

Pulmonary heart disease

3.58

7.82

1.1

—

Asthma-related pneumonia or sepsis

3.29

7.75

1.1

1.0

—

Asthma, hospital admissions 3, pneumonia

3.29

7.75

1.1

1.0

—

Hypertension, essential

2.82

7.72

1.0

1.1

—

Speech therapy

3.64

7.72

1.0

1.1

—

Complications of medical and surgical care

164

2.55

7.65

1.0

—

Cutaneous abscess, furuncle and carbuncle

3.97

7.60

1.1

1.0

—

Asthma

3.00

7.58

1.1

1.0

—

Amputation

5.61

7.53

1.0

—

Other diseases of blood and blood-forming organs, wide

4.23

7.46

1.1

1.0

—

Exposure to unspecified factor

190

2.29

7.41

1.1

1.0

—

Tramadol

119

2.54

7.40

1.0

1.1

—

Heart failure and coronary heart disease

3.46

7.19

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

109

2.44

7.16

1.0

—

Examination and observation for other reasons

2.68

7.06

1.0

1.1

—

Other disorders of kidney and ureter

5.66

7.06

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

146

2.59

6.95

1.0

—

Asthma, unspecified (mode)

3.42

6.91

1.1

1.0

—

COPD

2.87

6.77

1.1

1.0

—

Cardiomyopathy, other and unspecified

7.16

6.70

1.0

1.1

—

Explicit bacterial Sepsis

7.15

6.69

1.1

1.0

—

Codeine

129

2.30

6.67

1.1

—

Acute bronchitis

2.93

6.64

1.1

1.0

—

Diseases of the skin and subcutaneous tissue

123

2.28

6.63

1.1

1.0

—

Asthma (only as main-diagnosis)

2.93

6.63

1.1

1.0

—

Cellulitis

4.01

6.61

1.0

—

Seropositive rheumatoid arthritis

3.99

6.58

1.1

1.0

—

Other disorders of skin and subcutaneous tissue

148

2.48

6.56

1.1

1.0

—

Hard cardiovascular diseases

115

2.46

6.52

1.1

1.0

—

Direct fill therapy

5.21

6.48

1.0

—

Valvular heart disease excluding rheumatic fever

2.99

6.37

1.0

1.1

—

Amputation of toe

6.69

6.31

1.0

—

Protozoal diseases

18.15

6.27

1.2

1.0

—

Pericarditis

18.10

6.27

1.1

1.0

—

Other respiratory disorders and diseases

3.96

6.16

1.2

1.1

—

Other diseases of the respiratory system

3.96

6.16

1.2

1.1

—

Giant cell arteritis

12.58

6.08

1.1

—

Any reimbursement code in KELA

3.09

5.98

1.0

1.1

—

Rheumatoid arthritis, including avohilmo

2.92

5.98

1.0

—

Sulfasalazine

3.87

5.97

1.1

1.0

—

Other heart diseases, wide

124

2.30

5.92

1.0

—

Disorders resulting from impaired renal tubular function

15.09

5.90

1.0

—

Certain disorders involving the immune mechanism

4.01

5.89

1.0

1.1

—

Non-rheumatic valve diseases

2.88

5.81

1.0

1.1

—

Other chronic obstructive pulmonary disease

2.71

5.79

1.1

1.0

—

Vocal cord dysfunction

6.20

5.74

1.0

—

Purpura and other haemorrhagic conditions

5.01

5.74

1.0

—

Asthma, hospital admission 2, infections

141

2.44

5.70

1.1

1.0

—

Asthma-related infections

141

2.44

5.70

1.1

1.0

—

Intestinal infectious diseases

183

2.13

5.66

1.0

1.1

—

Pain in limb

141

2.26

5.65

1.0

1.1

—

Idiopathic gout

5.90

5.62

1.0

—

155

2.04

5.61

1.1

1.0

—

Cystitis

114

2.31

5.56

1.0

—

Myocardial infarction

2.61

5.56

1.1

—

Codeine or tramadol medication

168

2.01

5.54

1.1

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

3.19

5.39

1.1

—

Asthma (mode)

2.63

5.38

1.1

1.0

—

Atrial fibrillation and flutter with reimbursement

4.37

5.32

1.1

1.0

—

Other disorders involving the immune mechanism, not elsewhere classified

11.33

5.29

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

163

2.08

5.26

1.1

1.0

—

All influenza

3.85

5.25

1.1

1.0

—

Microscopic polyangiitis

+∞

5.23

1.0

0.0

—

STROKE

2.56

5.17

1.1

1.0

—

Other bacterial intestinal infections

4.01

5.16

1.0

—

Type 2 diabetes, wide definition

132

2.17

5.08

1.0

1.1

—

ILD-related respiratory insufficiency

13.42

5.08

1.1

1.0

—

Temporal arteritis

13.41

5.08

1.1

1.0

—

Major coronary heart disease event excluding revascularizations

110

2.32

5.05

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

155

2.23

5.01

1.0

1.1

—

Major coronary heart disease event

119

2.24

5.01

1.1

—

Early onset COPD, excluding more controls

4.78

5.00

1.2

1.0

—

Bacterial intestinal infections, IBD co-morbidities

3.89

4.98

1.0

—

COPD, hospital admission 2, with asthma infections

2.93

4.95

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

142

2.32

4.89

1.0

1.1

—

Cardiodefibrillation

100

2.60

4.86

1.0

1.1

—

COPD, early/later onset

103

2.46

4.85

1.1

1.0

—

Seropositive rheumatoid arthritis, strict definition

4.29

4.82

1.1

1.0

—

Parodontitis and operation codes

170

2.06

4.75

1.0

1.1

—

Opioids

130

2.02

4.59

1.0

1.1

—

Vasculitis limited to skin, not elsewhere classified

14.09

4.58

1.3

1.0

—

Implicit fungal Sepsis

14.07

4.58

1.0

—

Fungal Sepsis

14.06

4.58

1.0

—

Cough

2.91

4.57

1.3

1.0

—

Other specific joint derangements/joint disorders

112

2.22

4.54

1.0

—

Giant cell arteritis with polymyalgia rheumatica

10.05

4.52

1.1

1.0

—

Pain in joint

2.35

4.48

1.0

1.1

—

Headache

2.44

4.46

1.1

1.0

—

Unspecified acute lower respiratory infection

4.24

4.35

1.2

1.0

—

Parodontitis

172

1.97

4.31

1.0

1.1

—

Parodontitis or operation codes

172

1.97

4.30

1.0

1.1

—

Endocarditis

8.93

4.28

1.0

—

Other diseases of pericardium

8.92

4.28

1.3

1.0

—

Other disorders of white blood cells

8.92

4.28

1.3

1.0

—

Pneumonia due to other infectious organisms, not elsewhere classified

11.73

4.28

1.3

1.0

—

Preparatory care for dialysis

11.71

4.28

1.0

—

Chronic nephritic syndrome

11.71

4.28

1.0

—

Adjustment and management of implanted device

3.88

4.25

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

114

2.26

4.21

1.1

1.0

—

Chronic sinusitis

102

2.45

4.19

1.1

1.0

—

Mycoses

2.91

4.16

1.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

6.94

4.16

1.1

1.0

—

Myocardial infarction, strict

2.38

4.12

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

136

1.99

4.01

1.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.90

3.99

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

147

1.93

3.96

1.0

1.1

—

Later onset COPD

2.82

3.95

1.1

—

Insulin medication

138

2.11

3.94

1.0

1.1

—

COPD, hospital admissions

104

2.28

3.90

1.1

—

Myocardial infarction, without ST-elevation

2.38

3.90

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

151

2.08

3.86

1.0

1.1

—

Seropositive rheumatoid arthritis, wide

2.77

3.84

1.1

1.0

—

Bronchitis

187

1.82

3.83

1.1

1.0

—

Presence of cardiac and vascular implants and grafts

2.28

3.82

1.1

—

Persons encountering health services in other circumstances, wide

176

1.77

3.80

1.1

1.0

—

Lung cancer and mesothelioma

3.92

3.79

1.0

—

Suppurative and necrotic conditions of lower respiratory tract

8.78

3.77

1.0

—

Other and unspecified vasculitis limited to skin

12.07

3.77

1.3

1.0

—

Systemic lupus erythematosus

12.04

3.76

1.0

—

Dialysis

12.04

3.76

1.0

—

Oedema, not elsewhere classified

3.05

3.76

1.1

1.0

—

Deposits [accretions] on teeth

7.04

3.76

1.0

—

Other specified/unspecified arthritis

2.91

3.73

1.2

1.1

—

Biological medication for rheuma

4.00

3.69

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

2.05

3.67

1.0

1.1

—

Urticaria and erythema

2.60

3.63

1.1

1.0

—

Diseases of liver

2.47

3.62

1.0

1.1

—

Cardiac arrhythmias

2.29

3.61

1.0

—

Chronic periodontitis, including avohilmo

174

1.87

3.61

1.0

1.1

—

Nonischemic cardiomyopathy

7.80

3.56

1.0

—

Persons encountering health services for specific procedures, not carried out

7.79

3.56

1.0

—

Ischaemic heart disease, wide definition

116

2.00

3.53

1.0

1.1

—

Diseases of the respiratory system

2.30

3.52

1.0

—

COPD related to multimorbidity

2.32

3.51

1.1

—

Olecranon bursitis

6.17

3.50

1.0

1.1

—

Chronic lower respiratory diseases

177

1.74

3.50

1.1

1.0

—

Dental caries 3 and operation codes

126

1.87

3.50

1.0

1.1

—

Allergic purpura

10.04

3.50

1.0

—

Other diseases of intestines

166

1.79

3.46

1.1

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

2.76

3.41

1.0

1.1

—

Arthropathies

119

1.88

3.39

1.1

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.01

3.37

1.0

1.1

—

Agranulocytosis

5.01

3.37

1.0

—

Syncope and collapse

2.46

3.35

1.1

1.0

—

Depression medications

3.77

3.31

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.62

3.29

1.1

1.0

—

Other/unspecified seropositive rheumatoid arthritis

2.62

3.29

1.1

1.0

—

Diseases of pulp and periapical tissues

2.41

3.29

1.1

—

Symptoms and signs involving the urinary system

150

1.91

3.27

1.0

1.1

—

Abnormal findings on examination of urine, without diagnosis

8.60

3.26

1.3

1.0

—

Arterial embolism and thrombosis of lower extremity artery

8.60

3.26

1.0

—

Abnormalities of heart beat

2.69

3.26

1.0

—

Type 2 diabetes, definitions combined

144

1.82

3.23

1.0

1.1

—

Other arrhythmias

2.13

3.20

1.0

1.1

—

Other/unspecified rheumatoid arthritis

3.58

3.19

1.1

1.0

—

Pain, not elsewhere classified

2.86

3.18

1.0

—

103

2.22

3.15

1.1

1.0

—

Oxycodone

2.42

3.14

1.0

—

Other (seronegative) rheumatoid arthritis, wide

2.96

3.13

1.1

1.0

—

Type 2 diabetes, strict (exclude DM1)

146

1.80

3.11

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

116

2.10

3.09

1.0

1.1

—

Insulin, intermediate and long-acting

142

2.00

3.09

1.0

1.1

—

Ischemic heart diseases

118

1.91

3.08

1.0

1.1

—

Diabetes mellitus

160

1.75

3.06

1.0

1.1

—

Hypertrophic cardiomyopathy

7.53

3.05

1.2

1.0

—

Idiopathic pulmonary fibrosis

5.01

3.05

1.1

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

5.01

3.05

1.0

1.1

—

Other and unspecified local infections of skin and subcutaneous tissue

5.01

3.05

1.1

1.0

—

Cerebrovascular diseases

137

1.88

3.04

1.1

1.0

—

Soft tissue disorders related to use, overuse and pressure

2.58

3.03

1.0

1.1

—

Invasive ventilation

5.84

3.02

1.1

1.0

—

Diabetes, varying definitions

161

1.74

3.01

1.0

1.1

—

Pacemaker

2.37

3.01

1.1

—

Codes for special purposes

106

2.17

3.01

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

106

2.17

3.01

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

165

1.76

3.01

1.0

1.1

—

Unspecified privation

4.29

2.99

1.0

—

Systemic lupus erythematosus, unspecified

10.04

2.98

1.0

—

SLE, strict definition

10.03

2.98

1.0

—

SLE, ICD10

10.03

2.98

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

2.63

2.96

1.1

1.0

—

Parasetamol

107

1.86

2.95

1.1

1.0

—

Retention of urine

2.32

2.95

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

2.54

2.95

1.0

1.1

—

Bronchiectasis

4.72

2.92

1.5

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

2.09

2.91

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

132

2.00

2.89

1.0

—

Other/unspecified dorsalgia

2.31

2.87

1.0

—

Other coagulation defects

5.39

2.87

1.0

—

Other and unspecified psoriasis

6.68

2.87

1.2

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.15

2.85

1.0

1.1

—

Type 2 diabetes

150

1.74

2.82

1.0

1.1

—

Chronic periodontitis

3.06

2.80

1.1

—

Other local infections of skin and subcutaneous tissue

4.45

2.79

1.1

1.0

—

Other viral diseases

2.46

2.76

1.2

1.0

—

Metabolic disorders

154

1.73

2.76

1.0

1.1

—

Isolated proteinuria

8.37

2.75

1.4

1.0

—

Parodontitis or/and operation codes

1.98

2.74

1.0

—

Dental caries 1 and operation codes

122

1.77

2.74

1.0

1.1

—

Other infectious diseases

5.01

2.72

1.0

1.1

—

Chronic ulcer of skin, not elsewhere classified

5.01

2.72

1.1

1.0

—

Hydronephrosis

5.01

2.72

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

147

1.73

2.72

1.0

1.1

—

DVT of lower extremities

2.71

1.1

—

Chronic periapical parodontitis

2.71

1.2

1.1

—

Asthma and opportunity respiratory infection

6.02

2.70

1.2

1.0

—

Other aneurysm

6.01

2.70

1.0

—

Abrasion of teeth

2.81

2.70

1.0

—

Diagnoses used for exclusion with ILD

2.50

2.69

1.0

1.1

—

3.75

2.67

1.2

1.0

—

Diverticular disease of intestine

124

1.82

2.60

1.0

—

Candidiasis

3.60

2.57

1.0

—

Melanoma in situ

7.17

2.55

1.0

—

Recurring oral aphthae

7.16

2.55

1.0

—

Hypertensive heart and/or renal disease

2.58

2.54

1.1

1.0

—

Reactive arthropathies, FINNGEN

5.46

2.54

1.0

—

Gastrointestinal diseases

1.98

2.54

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

176

1.62

2.49

1.1

1.0

—

Cardiac arrest

7.19

2.49

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.32

2.47

1.3

1.0

—

Other cataract

2.02

2.46

1.1

1.0

—

Viral pneumonia

3.81

2.46

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

3.81

2.46

1.0

—

Coxarthrosis [arthrosis of hip](FG)

2.11

2.46

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

117

1.90

2.46

1.1

—

Hypothyroidism, levothyroxine purchases

3.70

2.41

1.0

1.1

—

Hypothyroidism and >3 levothyroxin purchases

3.70

2.41

1.0

1.1

—

Hypothyroidism (congenital or acquired)

3.69

2.41

1.0

1.1

—

Pleural effusion

2.94

2.41

1.1

—

Other diseases of liver

2.94

2.41

1.0

1.1

—

Arterial embolism and thrombosis

5.01

2.40

1.0

1.1

—

Disorders of lens

112

1.80

2.37

1.1

—

Melanoma in situ

6.27

2.37

1.0

—

Other diseases of the digestive system

2.21

2.37

1.1

—

GI-bleeding

2.21

2.36

1.1

—

Myocardial infarction, with ST-elevation

2.61

2.35

1.0

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

2.50

2.35

1.1

—

Polyuria

2.50

2.35

1.0

1.1

—

Postmenopausal atrophic vaginitis

0.00

2.35

0.0

1.1

—

Diseases of the musculoskeletal system and connective tissue

2.06

2.34

1.0

—

Dental caries 3

117

1.70

2.30

1.1

—

Disorders of thyroid, IBD co-morbidities

4.25

2.30

1.0

—

Enlarged lymph nodes

3.22

2.30

1.1

—

Disorders of sclera, cornea, iris and ciliary body

133

1.88

2.30

1.1

1.0

—

Corneal ulcer

2.86

2.30

1.3

1.0

—

Coronary revascularization (ANGIO or CABG)

1.98

2.29

1.1

—

Other disorders of teeth and supporting structures

2.45

2.27

1.0

1.1

—

Osteonecrosis

4.63

2.27

1.0

—

Aortic aneurysm

2.46

2.27

1.1

—

Orchitis and epididymitis

3.48

2.26

1.3

1.1

—

Genitourinary diseases

1.91

2.25

1.0

1.1

—

Overexertion and strenuous or repetitive movements

3.89

2.25

1.1

1.0

—

Covid-19 confirmed case

2.27

2.24

1.1

—

Secondary right heart disease

5.57

2.21

1.0

1.1

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

5.57

2.21

1.2

1.0

—

Other pulmonary heart/vessel disease

5.57

2.21

1.0

1.1

—

Melanocytic naevi, other sites/unspecified

5.56

2.21

1.0

—

Other inflammatory liver diseases

5.56

2.21

1.0

—

Acute pharyngitis

3.08

2.20

1.3

1.0

—

Gingivitis and periodontal diseases

128

1.65

2.20

1.0

1.1

—

Other and unspecified polyneuropathies, also in other diseases

2.50

2.18

1.1

—

Other disorders of lacrimal gland

2.13

2.18

1.1

1.0

—

Missing teeth due to accident, extraction or parodontitis

3.34

2.18

1.0

—

Stroke, including SAH

126

1.76

2.16

1.1

1.0

—

Acne vulgaris

4.29

2.15

1.0

—

Other pleural conditions

3.69

2.15

1.1

—

Diseases of the digestive system

115

1.91

2.13

1.1

—

Symptoms and signs involving the digestive system and abdomen

145

1.59

2.12

1.1

—

Neoplasms

102

1.73

2.11

1.0

—

Benign neoplasm: Colon

1.96

2.10

1.1

—

Constipation

172

1.62

2.10

1.1

1.0

—

Coronary atherosclerosis

110

1.76

2.10

1.1

—

Otitis externa

2.45

2.10

1.1

1.0

—

Recurring oral aphthae, including avohilmo

3.20

2.09

1.0

—

Dorsalgia

154

1.58

2.07

1.0

1.1

—

Nonsuppurative otitis media

2.47

2.07

1.2

1.0

—

Other/unspecified reactive arthropathies

5.01

2.07

1.0

—

Dermatographic urticaria

5.01

2.07

1.0

—

Unspecified haematuria

1.94

2.07

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.54

2.03

1.1

1.0

—

Dental pulpitis 1

165

1.54

2.02

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

165

1.54

2.02

1.0

—

Dental pulpitis 4

165

1.54

2.02

1.0

—

Ischaemic Stroke, excluding all haemorrhages

115

1.78

2.02

1.1

1.0

—

Sequelae with surgical and medical care as external cause

2.50

2.01

1.0

—

Diseases of salivary glands

2.50

2.01

1.0

—

Diabetes medication

166

1.57

2.00

1.0

1.1

—

Valvular operations

2.81

2.00

1.0

1.1

—

Hernia of abdominal wall, postoperative

2.81

2.00

1.1

1.0

—

Cholelithiasis, broad definition with cholecystitis

151

1.63

1.98

1.0

1.1

—

Coronary artery bypass grafting

2.20

1.98

1.1

—

Diseases of oesophagus, stomach and duodenum

181

1.54

1.97

1.1

1.0

—

Cholelithiasis

150

1.64

1.95

1.0

1.1

—

Stroke, excluding SAH

120

1.73

1.94

1.1

1.0

—

Melanocytic naevi, other sites/unspecified

4.55

1.94

1.0

—

Stomatitis and related lesions

4.55

1.94

1.0

—

Insulin, fast-acting

1.98

1.94

1.0

1.1

—

Inflammatory diseases of the central nervous system

4.55

1.94

1.0

—

Other diseases of biliary tract

3.75

1.93

1.0

1.1

—

Tumor necrosis factor alpha inhibitors

2.97

1.93

1.1

1.0

—

Arthropathic psoriasis

3.75

1.93

1.2

1.0

—

Other (not insulin) diabetes medications

153

1.58

1.88

1.1

—

Thoracic aortic aneurysm

2.65

1.86

1.0

1.1

—

Other viral diseases, not elsewhere classified

2.64

1.85

1.0

—

Disorders of lacrimal system

100

1.90

1.85

1.1

1.0

—

Hypertensive Heart Disease

2.43

1.83

1.0

1.1

—

Erectile dysfunction

3.53

1.83

1.0

—

Sicca syndrome [Sjögren]

3.53

1.83

1.2

1.0

—

Reactive arthropathies

3.53

1.83

1.0

—

Psoriatic arthropathies

3.53

1.83

1.2

1.0

—

Osteomyelitis

4.17

1.82

1.0

—

Injury of other and unspecified intrathoracic organs

4.17

1.82

1.2

1.0

—

Other diseases of hard tissues of teeth

123

1.70

1.82

1.0

1.1

—

Calcific aortic valvular stenosis

2.07

1.82

1.0

1.1

—

Calcific aortic valvular stenosis, operated

2.07

1.82

1.0

1.1

—

Operations 2 for CAVS

2.07

1.82

1.0

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.07

1.82

1.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

2.07

1.81

1.0

1.1

—

Non-invasive ventilation

2.56

1.78

1.1

1.0

—

Angina pectoris

1.74

1.75

1.0

1.1

—

Acne

3.33

1.74

1.0

—

Osteopathies and chondropathies

132

1.72

1.73

1.0

1.1

—

Abnormalities of gait and mobility

2.92

1.72

1.0

—

COPD-related respiratory insufficiency

2.92

1.72

1.1

1.0

—

Hyperkalaemia

3.85

1.71

1.0

1.1

—

Infectious mononucleosis

3.85

1.71

1.2

1.0

—

Undetermined asthma, excluding more controls

3.84

1.71

1.2

1.0

—

Hyperparathyroidism

2.41

1.71

1.1

1.0

—

Pure hypercholesterolaemia

128

1.62

1.70

1.0

1.1

—

Non-allergic asthma (mode), excluding more controls

2.89

1.70

1.0

—

Other CVD (FINNGEN)

3.94

1.68

1.2

1.0

—

Disorders of eyelid, lacrimal system and orbit

176

1.56

1.68

1.2

1.0

—

Spondylopathies

130

1.59

1.68

1.0

1.1

—

Tonsillectomy and adenotomy

0.37

1.67

1.0

—

Other psoriatic arthropathies

3.16

1.66

1.2

1.0

—

Psoriatic arthropathies, ICD10

3.16

1.66

1.2

1.0

—

Pruritus

3.16

1.66

1.0

1.1

—

Otitis externa, unspecified

3.16

1.66

1.0

—

Dental caries 2 and operation codes

154

1.60

1.66

1.0

1.1

—

Other functional intestinal disorders

1.83

1.65

1.2

1.0

—

Dental caries, including avohilmo

113

1.58

1.65

1.1

—

Dental caries 1

113

1.58

1.65

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

2.37

1.65

1.0

—

Insulin, fast-acting or short human

1.86

1.65

1.0

1.1

—

Sciatica+with lumbago

120

1.74

1.64

1.0

1.1

—

Spinal stenosis

104

1.73

1.64

1.0

1.1

—

Persons encountering health services in other circumstances

1.93

1.63

1.1

1.0

—

Dental caries 3, only avohilmo

126

1.54

1.62

1.1

—

In situ neoplasms

1.96

1.60

1.0

1.1

—

Coxarthrosis

1.81

1.60

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2.50

1.59

1.1

1.0

—

Abnormal serum enzyme levels

1.90

1.58

1.0

1.1

—

Psoriatic and enteropathic arthropathies

3.00

1.58

1.2

1.0

—

Mucosal proctocolitis

2.69

1.58

1.1

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

143

1.64

1.58

1.1

1.0

—

Abdominal and pelvic pain

145

1.49

1.57

1.1

—

Diabetic neuropathy

2.68

1.57

1.1

1.0

—

Other neurological diseases

146

1.60

1.56

1.0

1.1

—

Acute bronchiolitis

3.46

1.55

1.0

—

Diseases of oral cavity, salivary glands and jaws

128

1.52

1.54

1.1

—

Dementia in Alzheimer disease

0.00

1.54

0.0

1.1

—

Senile cataract

107

1.62

1.53

1.0

—

Fracture of lumbar spine and pelvis

2.27

1.52

1.0

—

Bronchitis, not specified as acute or chronic

3.34

1.52

1.0

—

Abnormal findings on diagnostic imaging of other body structures

2.59

1.51

1.1

1.0

—

Chronic laryngitis and laryngotracheitis

2.59

1.51

1.0

—

Ulcerative colitis, NAS

2.59

1.51

1.1

1.0

—

Alcohol abuse, main dg

2.59

1.51

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

1.96

1.50

1.1

—

Hypothyroidism, strict autoimmune

100

1.66

1.49

1.0

—

Soft tissue disorders

152

1.47

1.49

1.0

1.1

—

Non-allergic asthma (mode)

2.57

1.49

1.0

—

Other and unspecified urticaria

2.43

1.47

1.1

1.0

—

Biguanides

157

1.49

1.47

1.0

1.1

—

Other CVD

2.22

1.46

1.1

1.0

—

Statin medication

1.64

1.45

1.0

—

Other diseases of lip and oral mucosa

2.37

1.45

1.1

1.0

—

Zoster [herpes zoster]

2.37

1.45

1.0

—

Emergency coronary revascularization (for ACS)

110

1.63

1.45

1.1

—

Acute alcohol intoxication, ICD10

2.37

1.45

1.0

—

Other disorders of bone

2.37

1.45

1.0

1.1

—

Migraine without aura

2.50

1.45

1.0

—

Other disorders of veins

1.84

1.45

1.1

—

Other dorsopathies, not elsewhere classified

156

1.45

1.44

1.0

1.1

—

Other diseases of arteries and capillaries

3.13

1.44

1.0

1.1

—

Sequelae of injuries of upper limb

3.13

1.44

1.0

—

LSIL lesion of the cervix uteri

3.13

1.44

1.0

—

Undetermined asthma

3.12

1.43

1.2

1.0

—

Chronic pancreatitis

2.73

1.43

1.0

—

Fall on same level

189

1.42

1.43

1.1

1.0

—

Urticaria

2.03

1.43

1.1

1.0

—

Acute upper respiratory infections

187

1.44

1.42

1.1

1.0

—

Dental caries 2

159

1.53

1.42

1.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.98

1.41

1.0

1.1

—

Keratitis

1.82

1.41

1.2

1.0

—

Nerve, nerve root and plexus disorders

183

1.44

1.40

1.0

1.1

—

Other disorders of bladder

2.42

1.39

1.0

1.1

—

Other bursopathies

2.42

1.39

1.0

1.1

—

Alcohol abuse, main dg, excluding more controls

2.42

1.39

1.0

—

Melanocytic naevi

2.00

1.37

1.0

1.1

—

Premature rupture of membranes

0.00

1.37

0.0

1.0

—

Covid-19 suspected case

2.20

1.36

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

2.61

1.36

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.61

1.36

1.0

—

Other keratitis

2.61

1.36

1.3

1.0

—

Seronegative rheumatoid arthritis

2.61

1.36

1.0

—

Synovial cyst of popliteal space [Baker]

2.94

1.36

1.0

1.1

—

Emphysema

2.94

1.36

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

2.94

1.36

1.0

—

Melanocytic naevi of trunk

2.94

1.36

1.0

—

Disorders of parathyroid gland

2.15

1.35

1.1

1.0

—

Other female pelvic inflammatory diseases

0.00

1.34

0.0

1.0

—

Familial hypercholesterolemia

2.14

1.33

1.0

1.1

—

Early onset COPD

2.04

1.32

1.2

1.0

—

Gastroduodenal ulcer

1.91

1.32

1.2

1.1

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1.67

1.32

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

155

1.46

1.31

1.0

1.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.50

1.30

1.0

—

Other inflammation of eyelid

2.50

1.30

1.7

1.0

—

Migraine without aura and triptan purchases

2.50

1.30

1.0

—

Asthma, hospital admissions , main diagnosis only

201

1.47

1.30

1.1

1.0

—

COPD, hospital admissions 1, only main diagnosis

1.74

1.29

1.1

—

Asthma (diagnoses ohter than nonallergic)

199

1.46

1.29

1.1

1.0

—

Other abnormal uterine and vaginal bleeding

2.07

1.29

1.0

1.1

—

Disorders of the thyroid gland

167

1.45

1.29

1.0

—

Vitreous haemorrhage

2.78

1.28

1.0

—

Rosacea

2.78

1.28

1.0

—

Thyroiditis, ILD-related definition

2.78

1.28

1.0

—

Mental and behavioural disorders due to psychoactive substance use

159

1.54

1.28

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

172

1.44

1.28

1.1

1.0

—

Asthma, including avohilmo

197

1.39

1.27

1.1

1.0

—

Somatoform disorder

2.29

1.26

1.1

1.0

—

All dysplastic lesions of the cervix uteri

2.28

1.26

1.0

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1.64

1.26

1.0

1.1

—

Dermatophytosis

2.40

1.24

1.0

—

Intracerebral haemorrhage

2.40

1.24

1.0

—

Convulsions, not elsewhere classified

2.06

1.23

1.2

1.0

—

Injuries to the head

201

1.39

1.23

1.1

1.0

—

Transport accidents

102

1.65

1.22

1.2

1.1

—

Chronic periodontitis, complicated

2.63

1.21

1.0

—

Other complications of surgical and medical care, not elsewhere classified

2.63

1.21

1.0

1.1

—

Melanocytic naevi of trunk

2.63

1.21

1.0

—

Supervision of normal pregnancy

0.00

1.21

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1.62

1.20

1.0

1.1

—

In situ neoplasms

1.74

1.18

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

189

1.41

1.18

1.0

1.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

2.00

1.16

1.0

—

Substance abuse, excluding more controls

137

1.53

1.16

1.0

1.1

—

Benign neoplasm: Transverse colon

2.50

1.15

1.2

1.1

—

Disorders of muscles

2.50

1.15

1.0

1.1

—

Diabetic retinopathy, excluding more controls

2.09

1.15

1.1

—

Mental and behavioural disorders due to alcohol

138

1.55

1.14

1.0

1.1

—

Unstable angina pectoris

1.70

1.13

1.0

1.1

—

Melanocytic naevi

1.85

1.13

1.0

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

2.00

1.12

1.0

1.1

—

Gastric ulcer

2.00

1.12

1.3

1.1

—

Dental caries 1, only avohilmo

121

1.44

1.11

1.1

—

Dermatitis

151

1.52

1.11

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.26

1.10

1.0

—

Neurological diseases, wide definition

2.15

1.10

1.0

—

Obesity

150

1.52

1.09

1.1

1.0

—

Fitting and adjustment of other devices

1.74

1.09

1.0

1.1

—

Obesity, other/unspecified

1.82

1.08

1.1

1.0

—

Benign neoplasm: Colon

133

1.55

1.08

1.1

1.0

—

Malignant melanoma

2.19

1.08

1.0

—

Cholecystitis

2.19

1.08

1.0

1.1

—

Dementia

0.47

1.07

1.0

1.1

—

Other arthrosis

1.60

1.07

1.1

1.0

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1.56

1.06

1.0

1.1

—

Superficial injury of head

1.92

1.06

1.0

—

Hyperlipidaemia, other/unspecified

1.65

1.05

1.0

1.1

—

Lower back pain or/and sciatica

198

1.37

1.04

1.0

1.1

—

Obesity and other hyperalimentation

152

1.50

1.04

1.1

1.0

—

Benign neoplasm: Transverse colon

2.27

1.03

1.2

1.1

—

Pedal cyclist injured in noncollision transport accidents

2.27

1.03

1.2

1.0

—

Subarachnoid haemorrhage

2.27

1.03

1.0

—

Nontraumatic intracranial haemmorrhage

1.96

1.03

1.0

1.1

—

Leiomyoma of uterus

1.58

1.03

1.0

—

Other gastritis (incl. Duodenitis)

1.83

1.02

1.0

1.1

—

Abdominal aortic aneurysm (AAA)

2.26

1.02

1.2

1.0

—

Iridocyclitis

1.92

1.02

1.0

—

Injuries to the shoulder and upper arm

199

1.39

1.01

1.0

1.1

—

Diabetic retinopathy

1.66

1.00

1.1

1.0

—

Substance abuse

156

1.47

1.00

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

1.45

0.99

1.1

—

Bell's palsy

2.18

0.98

1.0

—

Duodenal ulcer

2.17

0.98

1.0

—

Vitamin B12 deficiency anaemia

2.17

0.98

1.2

1.0

—

All influenza (not pneumonia)

2.17

0.98

1.0

—

Use of rivastigmine

0.00

0.97

0.0

1.0

—

Medical treatment for female infertility

0.00

0.97

0.0

1.0

—

Acute sinusitis

115

1.54

0.97

1.2

1.0

—

Psoriasis vulgaris

1.95

0.97

1.1

—

Use of pramipexole

1.80

0.96

1.0

—

Obesity due to excess calories

108

1.57

0.96

1.1

1.0

—

Other and unspecified dermatitis

116

1.55

0.96

1.1

—

Erosion of teeth, including avohilmo

1.93

0.96

1.0

—

Persons encountering health services in circumstances related to reproduction

100

0.54

0.95

1.0

—

Asthma/COPD (KELA code 203)

175

1.37

0.94

1.1

1.0

—

Lichen planus

2.22

0.93

1.2

1.0

—

Other metabolic disorders

2.22

0.93

1.0

—

Lesion of ulnar nerve

2.22

0.93

1.0

1.1

—

Chondropathies

2.22

0.93

1.0

1.1

—

Acute suppurative otitis media

1.75

0.93

1.0

—

Basal cell carcinoma

125

1.47

0.93

1.0

—

Superficial injury of lower leg

1.82

0.92

1.0

—

Dorsopathies

157

1.33

0.91

1.0

1.1

—

Congenital malformations of the circulatory system

2.15

0.91

1.0

—

153

1.44

0.91

1.0

1.1

—

Follow-up examination after treatment for malignant neoplasms

2.14

0.91

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

137

1.38

0.91

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

137

1.38

0.91

1.0

1.1

—

Organic, including symptomatic, mental disorders

112

0.58

0.90

1.0

1.1

—

Papulosquamous disorders

1.60

0.90

1.1

—

Dementia, including avohilmo

0.53

0.90

1.0

1.1

—

Type 1 diabetes

1.74

0.89

1.0

1.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

2.00

0.87

1.0

1.1

—

Other medical care

1.61

0.87

1.0

1.1

—

Superficial injury of hip and thigh

2.00

0.87

1.0

—

Polyarthrosis

1.83

0.86

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

145

1.40

0.85

1.0

—

Benign neoplasm: Sigmoid colon

1.82

0.85

1.3

1.1

—

Acute pancreatitis (for exclusion)

1.82

0.85

1.0

—

Type 1 diabetes, wide definition, subgroup 1

1.82

0.85

1.0

—

Any mental disorder

165

1.30

0.85

1.0

1.1

—

Symptoms and signs involving speech and voice

1.63

0.84

1.0

1.1

—

Chronic diseases of tonsils and adenoids

145

0.65

0.84

1.0

—

Nontoxic multinodular goitre

1.78

0.84

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.45

0.83

1.0

1.1

—

Basal cell carcinoma, including avohilmo

127

1.43

0.83

1.0

—

Ovarian cyst

1.62

0.82

1.0

—

Psoriasis

1.69

0.82

1.1

1.0

—

Disorders of other endocrine glands

103

1.53

0.82

1.1

1.0

—

Other nutritional deficiencies

159

1.41

0.82

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

177

1.31

0.82

1.0

1.1

—

Disorder of lipoprotein metabolism, unspecified

1.88

0.81

1.2

1.1

—

Injury of muscle and tendon at lower leg level

1.88

0.81

1.2

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.87

0.81

1.0

—

Psychiatric diseases

162

1.30

0.81

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

1.46

0.81

1.0

—

Spondylosis

118

1.45

0.80

1.0

1.1

—

Acute pancreatitis

1.70

0.80

1.0

—

Special screening examination for infectious and parasitic diseases

1.71

0.80

1.1

1.0

—

Perineal laceration during delivery

0.00

0.79

0.0

1.0

—

Flat foot [pes planus] (acquired)

0.00

0.79

0.0

1.0

—

Lung diseases due to external agents

1.82

0.79

1.0

1.1

—

Benign neoplasm: Sigmoid colon

1.67

0.78

1.3

1.0

—

Atopic dermatitis

104

1.48

0.78

1.1

1.0

—

Chronic gastritis

1.67

0.78

1.1

—

Exposure to other specified factors

186

1.36

0.78

1.0

1.1

—

Tooth eruption problems

0.00

0.78

0.0

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

146

1.35

0.78

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.57

0.78

1.1

1.0

—

Anxiety disorders, excluding more controls

142

1.35

0.77

1.1

—

Cholecystectomy

153

1.39

0.77

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.38

0.77

1.0

1.1

—

Hypotension

1.76

0.76

1.2

1.1

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

137

1.34

0.76

1.0

1.1

—

Acute alcohol intoxication

1.70

0.75

1.0

1.1

—

Nausea and vomiting

1.70

0.75

1.1

1.0

—

Sensorineural hearing loss

145

1.35

0.75

1.1

1.0

—

Pregnancy with abortive outcome

1.45

0.75

1.0

—

Amiodarone users

2.08

0.74

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2.08

0.74

1.0

—

Ulcerative colitis

1.64

0.73

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

108

1.48

0.73

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.62

0.73

1.0

1.1

—

Hallux valgus (acquired)

1.61

0.72

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2.00

0.72

1.0

—

Noninfectious colitis NAS

2.00

0.72

1.0

—

Other diseases of intestine

2.00

0.72

1.2

1.0

—

Ectopic pregnancy

2.00

0.72

1.0

—

Colectomy operation

1.80

0.72

1.0

—

Fracture of foot, except ankle

1.61

0.72

1.0

—

Dermatitis and eczema

206

1.27

0.72

1.1

1.0

—

Fibroblastic disorders

1.67

0.72

1.1

—

Other and unspecified effects of external causes

1.67

0.72

1.0

—

Deviated nasal septum

1.52

0.72

1.0

1.1

—

Sequelae of external causes of morbidity and mortality

1.62

0.71

1.0

1.1

—

Palmar fascial fibromatosis [Dupuytren]

1.75

0.71

1.1

—

Other/unspecified synovitis and tenosynovitis

1.92

0.70

1.0

1.1

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1.56

0.70

1.0

1.1

—

Lichen planus, including avohilmo

1.71

0.70

1.1

1.0

—

Adverse effects, not elsewhere classified

1.71

0.70

1.0

—

Low back pain

149

1.34

0.69

1.0

1.1

—

Disorders of vitreous body and globe

123

1.43

0.69

1.1

—

Dental pulpitis 2, only avohilmo

107

1.34

0.69

1.0

1.1

—

Abnormal involuntary movements

1.85

0.68

1.0

—

159

1.35

0.68

1.0

1.1

—

5-aminosalicylic acid

1.85

0.68

1.2

1.0

—

Coronary angioplasty

1.51

0.68

1.0

1.1

—

Dysphagia

1.64

0.68

1.0

1.1

—

Nontoxic goitre/thyroid nodule

1.59

0.68

1.0

—

Other symptoms and signs involving cognitive functions and awareness

111

1.44

0.67

1.0

1.1

—

Other diseases of upper respiratory tract

174

1.26

0.67

1.1

1.0

—

Dental pulpitis 2

103

1.34

0.67

1.0

1.1

—

Use of hypnotics and sedatives

178

1.27

0.67

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

169

1.35

0.67

1.1

1.0

—

Diseases of the ear and mastoid process

178

1.25

0.67

1.1

1.0

—

Fracture of forearm

127

1.40

0.67

1.0

—

Ethmoidectomy

1.79

0.66

1.2

1.0

—

Primary coxarthrosis, bilateral

1.54

0.65

1.0

1.1

—

Other enthesopathies

1.61

0.65

1.0

—

Benign neoplasms

153

1.28

0.64

1.1

1.0

—

Benign neoplasm: Ascending colon

1.72

0.64

1.4

1.0

—

Misadventures to patients during surgical and medical care

1.72

0.64

1.0

—

Sarcoidosis

1.67

0.61

1.0

—

Insulin, fast-acting (human)

1.67

0.61

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.33

0.61

1.0

1.1

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

0.61

0.0

1.1

—

Personality disorders, excluding more controls

1.57

0.60

1.0

—

Type 1 diabetes, wide definition

1.57

0.60

1.0

—

Allergic asthma (mode), excluding more controls

1.64

0.60

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.60

0.0

1.0

—

Ménière disease

0.00

0.60

0.0

1.0

—

Dysplasia of cervi uteri

1.55

0.59

1.0

1.1

—

Other intervertebral disc disorders

143

1.28

0.59

1.0

1.1

—

Fracture of skull and facial bones

1.54

0.59

1.0

—

Personality disorders

1.54

0.59

1.0

—

Presence of other devices

1.54

0.59

1.0

—

Acetic acid derivatives and related substances

1.51

0.59

1.1

1.0

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.59

0.0

1.0

—

Deforming dorsopathies

1.56

0.58

1.0

—

Dental operations, only avohilmo

106

1.30

0.58

1.0

1.1

—

Impacted cerumen

0.00

0.58

0.0

1.0

—

Disorders of choroid and retina

165

1.28

0.58

1.0

1.1

—

Wet age-related macular degeneration

1.73

0.58

1.0

1.1

—

Thyrotoxicosis

1.48

0.57

1.0

—

Disorders of vitreous body

121

1.38

0.56

1.1

—

Subjective visual disturbances

1.45

0.56

1.1

1.0

—

Injuries to the elbow and forearm

167

1.30

0.55

1.0

1.1

—

Aneurysms, operations, SAH

1.62

0.55

1.0

—

Sub-endpoint used in defining T1D endpoints

1.50

0.55

1.0

—

Conductive and sensorineural hearing loss

152

1.28

0.55

1.1

1.0

—

Car occupant injured in other and unspecified transport accidents

1.58

0.54

1.3

1.1

—

Falls/tendency to fall

168

1.22

0.54

1.1

1.0

—

Functional dyspepsia

1.50

0.54

1.0

—

Benign lipomatous neoplasm

1.50

0.54

1.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.48

0.53

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.49

0.53

1.0

—

Any dementia, excluding more controls

0.60

0.53

1.0

1.1

—

Viral and other specified intestinal infections

1.54

0.53

1.0

—

Long labour

1.54

0.53

1.0

—

Other skin changes

1.54

0.53

1.0

1.1

—

Dental pulpitis 4, only avohilmo

176

1.22

0.52

1.0

—

Any dementia

0.59

0.52

1.0

1.1

—

Injuries to the ankle and foot

162

1.29

0.52

1.0

1.1

—

Voice disturbances

1.43

0.52

1.0

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.60

0.52

1.0

—

Infections with a predominantly sexual mode of transmission

1.43

0.52

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.51

0.52

1.0

1.1

—

Disorders of skin appendages

117

1.37

0.52

1.1

1.0

—

Adhesive capsulitis of shoulder

1.50

0.51

1.0

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

100

0.60

0.51

1.2

1.1

—

Complications of labour and delivery

0.68

0.51

1.1

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.48

0.50

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.38

0.50

1.0

—

Other blood glucose lowering drugs, excl. Insulins

1.46

0.50

1.0

1.1

—

Striking against or struck by other objects

1.43

0.49

1.0

—

Internal derangement of knee

1.43

0.48

1.0

—

Other joint disorders

119

1.25

0.47

1.0

—

Anterior Iridocyclitis

1.49

0.47

1.0

—

Specific personality disorders

1.49

0.47

1.0

—

Accidents

121

1.24

0.47

1.0

—

Radiculopathy

1.46

0.46

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.46

0.46

1.1

1.0

—

Haemorrhage in early pregnancy

1.45

0.46

1.0

—

Gonarthrosis, primary, with knee surgery

135

0.73

0.46

1.0

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

102

1.36

0.45

1.0

1.1

—

Episodal and paroxysmal disorders

176

1.19

0.45

1.1

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.29

0.44

1.0

—

Primary gonarthrosis, bilateral

123

0.71

0.43

1.0

1.1

—

Other disorders of ear

176

1.21

0.43

1.2

1.0

—

Mixed conductive and sensorineural hearing loss

1.61

0.43

1.0

—

Other disorders of the musculoskeletal system and connective tissue

1.61

0.43

1.2

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.61

0.43

1.2

1.0

—

Dentofacial anomalies [including malocclusion]

1.44

0.42

1.0

—

Other and unspecified tonsillitis

1.41

0.42

1.1

1.0

—

Disorders of adult personality and behaviour

1.43

0.42

1.0

—

Benign neoplasm: Ascending colon

1.56

0.42

1.4

1.1

—

TMD related operations

1.56

0.42

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

163

1.21

0.42

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.39

0.41

1.1

1.0

—

Crossbite

0.00

0.41

0.0

1.0

—

Sequelae of cerebrovascular disease

1.36

0.41

1.0

1.1

—

Irritable bowel syndrome

1.38

0.41

1.0

—

Single spontaneous delivery

0.67

0.41

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.52

0.41

1.0

—

Ulcerative colitis (strict definition, require KELA)

1.52

0.41

1.2

1.0

—

Inflammatory disease of cervix uteri

0.00

0.41

0.0

1.1

—

Benign neoplasm of middle ear and respiratory system

0.00

0.41

0.0

1.0

—

Other obstructed labour

0.00

0.41

0.0

1.0

—

Multiple delivery

0.00

0.41

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

0.41

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.41

0.0

1.0

—

Fibromyalgia

0.00

0.41

0.0

1.1

—

Pilonidal cyst

0.00

0.41

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.41

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.41

0.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.41

0.0

1.0

—

Arthrosis

1.27

0.41

1.0

1.1

—

Dental pulpitis 1, only avohilmo

177

1.18

0.41

1.1

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

107

1.30

0.40

1.1

1.0

—

Allergic asthma (mode)

1.49

0.40

1.0

—

Other diseases of oesophagus

0.00

0.40

0.0

1.1

—

Early lumbar disc prolapse, operated

0.00

0.40

0.0

1.1

—

Early lumbar disc prolapse operation

0.00

0.40

0.0

1.1

—

Use of levodopa decarboxylase inhibitor

1.47

0.40

1.0

1.1

—

Schizophrenia

1.47

0.40

1.0

—

Suppurative and unspecified otitis media

1.39

0.40

1.0

—

Other and/or unspecified nontoxic goitre

0.00

0.40

0.0

1.1

—

Deep endometriosis

0.00

0.40

0.0

1.1

—

Abnormalities of forces of labour

0.00

0.40

0.0

1.0

—

Diseases of male genital organs

0.77

0.40

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

141

1.28

0.40

1.1

—

Mood disorders

200

0.82

0.39

1.0

1.1

—

Other retinal disorders

142

1.24

0.39

1.0

1.1

—

Sulfonylureas

1.33

0.39

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

111

1.28

0.39

1.1

1.0

—

Certain conditions originating in the perinatal period

0.00

0.39

0.0

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1.43

0.39

1.0

—

Mood [affective] disorders

200

0.82

0.39

1.0

1.1

—

Fracture of shoulder and upper arm

1.34

0.39

1.0

—

Fracture of rib(s), sternum and thoracic spine

1.41

0.39

1.3

1.1

—

Chalazion

0.00

0.39

0.0

1.0

—

Presence of other functional implants

106

1.27

0.39

1.1

1.0

—

Transient ischemic attack

117

1.27

0.39

1.1

1.0

—

Primary open-angle glaucoma, strict

1.32

0.37

1.2

1.1

—

Parkinson's disease, strict definition, excluding more controls

1.36

0.37

1.0

1.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.35

0.37

1.2

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.27

0.36

1.0

—

Temporomandibular joint disorders, including avohilmo

1.36

0.36

1.0

—

Benign neoplasms

106

1.23

0.35

1.0

1.1

—

Diseases of external ear

1.33

0.35

1.1

—

Extrapyramidal and movement disorders

1.33

0.35

1.0

1.1

—

Any event in cancer register

144

1.19

0.35

1.0

1.1

—

Benign neoplasm: Rectum

1.43

0.35

1.0

1.1

—

Acute and subacute iridocyclitis

1.43

0.35

1.0

—

Poisoning by medicine

1.43

0.35

1.0

—

Thyrotoxicosis, other and/or unspecified

1.36

0.34

1.0

—

Benign neoplasm: Rectum, anus and anal canal

1.36

0.34

1.0

1.1

—

Migraine

1.29

0.34

1.1

1.0

—

Coxarthrosis, primary

141

1.23

0.34

1.1

—

Macular pucker

1.33

0.33

1.0

1.1

—

Injuries to the neck

1.33

0.33

1.0

—

Other fall from one level to another

1.33

0.33

1.0

—

Dental operations

1.22

0.33

1.0

1.1

—

Benign neoplasm: Rectum

1.30

0.33

1.0

1.1

—

Diseases of appendix

191

0.81

0.32

1.0

1.1

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.30

0.32

1.0

1.1

—

Myalgia

1.28

0.32

1.0

—

Suicide or other Intentional self-harm

1.28

0.32

1.0

—

Other maternal disorders predominantly related to pregnancy

1.27

0.32

1.0

—

Neurotic, stress-related and somatoform disorders

182

1.17

0.32

1.1

—

Meniscus derangement

1.26

0.31

1.0

1.1

—

Anxiety disorders

182

1.17

0.31

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.32

0.30

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.32

0.30

1.0

—

Dental caries 2, only avohilmo

159

1.19

0.30

1.0

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.30

0.30

1.0

1.1

—

Disturbances of skin sensation

1.30

0.30

1.1

1.0

—

Disorders of refraction and accommodation

1.29

0.30

1.0

—

Dizziness and giddiness

164

1.19

0.30

1.0

—

Open wound of head

145

1.22

0.30

1.1

—

Disorders of conjunctiva

185

1.18

0.30

1.0

—

Mouth breathing

111

1.26

0.29

1.1

—

Appendicitis, broad definition

189

0.82

0.29

1.0

1.1

—

Coxibs

1.30

0.29

1.1

1.0

—

Osteoporosis

1.24

0.29

1.0

—

Other noninfective gastroenteritis and colitis

1.23

0.29

1.0

—

All anxiety disorders

119

1.22

0.28

1.1

1.0

—

Noninfective enteritis and colitis

121

1.24

0.28

1.1

1.0

—

Inflammatory bowel disease

1.32

0.28

1.2

1.0

—

Rotator cuff syndrome

117

1.21

0.27

1.1

—

Hypothyroidism, other/unspecified

153

1.16

0.27

1.0

1.1

—

Conjunctivitis (acute, non atopic)

1.25

0.27

1.0

—

Recurrent or chronic depression

1.27

0.26

1.1

1.0

—

Postmenopausal bleeding

1.27

0.26

1.0

1.1

—

Diseases of middle ear and mastoid

130

1.20

0.26

1.1

—

Other anxiety disorders

1.25

0.26

1.1

1.0

—

Allergic rhinitis

0.70

0.26

1.0

—

Dental caries 3 and operation codes, only avohilmo

1.32

0.26

1.1

—

Pregnancy, childbirth and the puerperium

1.21

0.25

1.0

—

Female genital prolapse

1.21

0.25

1.0

—

Leiomyoma of uterus

1.31

0.25

1.0

—

Benign lipomatous neoplasm

1.22

0.25

1.0

1.1

—

Other diseases of anus and rectum

1.22

0.25

1.2

1.0

—

Other hearing loss

1.18

0.24

1.2

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.28

0.24

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

157

0.83

0.23

1.0

1.1

—

Other disorders of eyelid

111

1.22

0.23

1.1

1.0

—

Other hammer toe(s) (acquired)

1.34

0.23

1.0

—

Delivery, wide proxy

0.74

0.23

1.0

—

Disorders of synovium and tendon

112

1.21

0.23

1.0

1.1

—

Parkinson's disease, strict definition

1.28

0.23

1.0

1.1

—

Parkinson's disease

1.28

0.23

1.0

1.1

—

Parkinson's disease, including avohilmo

1.28

0.23

1.0

1.1

—

Substance use, excluding alcohol

1.28

0.23

1.0

—

Bipolar affective disorders

1.28

0.23

1.0

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1.28

0.22

1.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1.28

0.22

1.0

—

Other obstetric conditions, not elsewhere classified

1.25

0.22

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.25

0.22

1.0

—

Parkinson's disease, excluding more controls

1.25

0.22

1.0

1.1

—

Non-small cell lung cancer

1.25

0.22

1.0

1.1

—

Kela-code for severe mental illness

0.74

0.22

1.0

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1.24

0.22

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.26

0.22

1.0

—

Spondylolisthesis/Spondylolysis

1.22

0.22

1.0

—

Delivery

0.76

0.22

1.0

—

Persons encountering health services for examination and investigation

1.16

0.21

1.0

1.1

—

Nasal polyp

1.19

0.21

1.2

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.21

0.0

1.1

—

Other disorders starting during childhood or adolescence

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.1

—

Erosion and ectropion of cervix uteri

0.00

0.21

0.0

1.0

—

Mental retardation

0.00

0.21

0.0

1.0

—

Mental retardation, wide definition

0.00

0.21

0.0

1.0

—

Benign neoplasm: Small intestine

0.00

0.21

0.0

1.0

—

Other and unspecified abdominal hernia

0.00

0.21

0.0

1.0

—

Oligomenorrhoea

0.00

0.21

0.0

1.1

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.21

0.0

1.1

—

Calculus of lower urinary tract

0.00

0.21

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.21

0.0

1.0

—

Impotence

0.00

0.21

0.0

1.0

—

Dermatitis due to substances taken internally

0.00

0.21

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Cholangitis (primary sclerosing, PSC)

0.00

0.21

0.0

1.0

—

Failed induction of labour

0.00

0.21

0.0

1.0

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.21

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.21

0.0

1.0

—

Ulcerative proctitis

0.00

0.21

0.0

1.0

—

Inflammatory disorders of breast

0.00

0.21

0.0

1.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.0

—

Nonspecific lymphadenitis

0.00

0.21

0.0

1.0

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

0.21

0.0

1.0

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

1.0

—

Other diseases of jaws

0.00

0.21

0.0

1.0

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.0

—

Unknown and unspecified causes of morbidity

0.00

0.21

0.0

1.1

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.21

0.0

1.0

—

Oesophagitis

0.00

0.21

0.0

1.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Other specified/unspecified bacterial intestinal infections

0.00

0.21

0.0

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Use of galantamine

0.00

0.21

0.0

1.1

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.21

0.0

1.0

—

Obsessive-compulsive disorder

0.00

0.21

0.0

1.0

—

Left bundle-branch block

0.00

0.21

0.0

1.1

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.21

0.0

1.0

—

Assault by bodily force

0.00

0.21

0.0

1.0

—

Other puerperal infections

0.00

0.21

0.0

1.0

—

Disorders of breast

0.79

0.21

1.0

—

Unspecified mental disorder

101

0.79

0.21

1.0

—

Malignant neoplasm of digestive organs

104

0.76

0.21

1.1

—

Non-small cell lung cancer, adenocarcinoma

0.00

0.21

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

0.21

0.0

1.0

—

Acute gastritis

0.00

0.21

0.0

1.1

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Heterophoria

0.00

0.21

0.0

1.0

—

Twin gestation

0.00

0.21

0.0

1.0

—

Multiple gestation

0.00

0.21

0.0

1.0

—

Diaphragmatic hernia

1.24

0.20

1.0

1.1

—

Open wound of wrist and hand

125

1.19

0.20

1.0

1.1

—

Gonarthrosis

1.17

0.20

1.1

—

Hernia of abdominal wall

123

0.81

0.20

1.1

—

Postmenopausal osteoporosis with pathological fracture

0.00

0.20

0.0

1.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

0.20

0.0

1.0

—

Other diseases of pancreas

0.00

0.20

0.0

1.1

—

Benign neoplasm of middle ear and respiratory system

0.00

0.20

0.0

1.1

—

Foreign body entering into or through eye or natural orifice

0.00

0.20

0.0

1.0

—

Other appendicitis

0.00

0.20

0.0

1.0

—

Post-traumatic stress disorder

0.00

0.20

0.0

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

139

1.17

0.20

1.0

—

Poisoning by drugs, medicaments and biological substances

1.25

0.20

1.0

—

Preterm labour and delivery

1.25

0.20

1.2

1.0

—

Pedal cyclist injured in transport accident

1.22

0.20

1.2

1.0

—

Selective serotonin reuptake inhibitors

171

0.89

0.19

1.1

—

Depression

194

0.89

0.19

1.0

1.1

—

severe traumatic brain injury, does not include concussion

1.18

0.19

1.2

1.1

—

Benign neoplasm: Rectum, anus and anal canal

1.15

0.19

1.0

1.1

—

Benzodiazepine use

205

1.11

0.19

1.1

1.0

—

Neurological diseases

135

1.12

0.19

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

118

1.19

0.19

1.0

1.1

—

Acute appendicitis

185

0.87

0.18

1.0

1.1

—

Epilepsy

1.23

0.18

1.2

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.19

0.18

1.0

1.1

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.19

0.18

1.0

1.1

—

Fissure and fistula of anal and rectal regions

1.19

0.18

1.4

1.1

—

Diseases of inner ear

135

1.16

0.17

1.0

1.1

—

Dental caries 1 and operation codes, only avohilmo

1.22

0.17

1.1

—

Fracture of femur

1.14

0.17

1.0

1.1

—

Diseases of the eye and adnexa

116

1.12

0.17

1.0

—

Atopic dermatitis, strict definition

1.12

0.17

1.1

1.0

—

Other external causes of accidental injury

121

1.12

0.17

1.0

—

Excessive attrition of teeth

1.23

0.17

1.0

—

Conjunctivitis

170

1.13

0.17

1.0

1.1

—

L02BG Aromatase inhibitors

0.75

0.17

1.0

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

0.73

0.17

1.2

1.1

—

Unspecified fall

128

1.16

0.17

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

124

1.15

0.16

1.0

—

Intracranial injury

143

1.15

0.16

1.2

1.0

—

Injury, poisoning and certain other consequences of external causes

0.86

0.16

1.0

—

Dental caries 2 and operation codes, only avohilmo

121

1.13

0.16

1.0

—

Benign paroxysmal vertigo

1.13

0.16

1.0

—

Colonic or urogenital fistula

1.13

0.16

1.4

1.1

—

Malignant neoplasm of skin

133

1.13

0.16

1.0

1.1

—

Sleep disorders (combined)

191

1.10

0.16

1.1

1.0

—

Combinations of oral blood glucose lowering drugs

1.10

0.15

1.0

1.1

—

Medicines for HER+ breast cancer

0.79

0.15

1.0

—

Blepharochalasis

0.77

0.15

1.2

1.0

—

Menorrhagia

1.11

0.15

1.0

—

Depression or dysthymia

115

1.12

0.15

1.0

1.1

—

Malignant neoplasm

145

1.10

0.15

1.0

1.1

—

Lumbar disc prolapse

134

1.13

0.14

1.0

1.1

—

Noninflammatory disorders of female genital tract

0.80

0.14

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.80

0.14

1.0

—

Persons with potential health hazards related to communicable diseases

1.19

0.14

1.1

1.0

—

Inflammatory diseases of female pelvic organs

0.85

0.14

1.0

—

Non-selective monoamine reuptake inhibitors

0.80

0.13

1.0

1.1

—

Gastro-oesophageal reflux disease

159

1.11

0.13

1.1

1.0

—

Injuries to the thorax

113

1.15

0.13

1.2

1.0

—

Carpal tunnel syndrome

134

0.88

0.13

1.0

1.1

—

Actinic keratosis

1.15

0.12

1.0

1.1

—

Appendectomy

162

0.89

0.12

1.0

1.1

—

Medical abortion

1.13

0.11

1.0

—

Varicose veins

127

0.89

0.11

1.0

1.1

—

Intracranial trauma

114

1.11

0.11

1.2

1.0

—

Injuries to the knee and lower leg

204

1.07

0.10

1.1

1.0

—

Gonarthrosis,primary

170

0.92

0.10

1.0

1.1

—

Other antidepressants

171

1.07

0.10

1.1

—

Triptan medication for migraine, single purchase ok

134

0.91

0.10

1.1

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

134

0.91

0.10

1.1

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

100

1.14

0.10

1.0

—

Focal epilepsy

1.11

0.09

1.4

1.0

—

Inflammatory bowel disease, strict (require KELA)

1.09

0.09

1.2

1.0

—

IBD patients in KELA-register

1.09

0.09

1.2

1.0

—

Disorders of vestibular function (Vertigo)

115

1.12

0.09

1.0

1.1

—

Enthesopathies of lower limb, excluding foot

1.06

0.09

1.0

—

Gestational diabetes (for exclusion)

1.04

0.09

1.0

—

Migraine with aura

1.04

0.09

1.2

1.0

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1.15

0.09

1.1

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1.15

0.09

1.1

—

Artrosis, including avohilmo

138

1.07

0.09

1.0

1.1

—

Hyperplasia of prostate

0.88

0.09

1.0

1.1

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1.13

0.09

1.1

—

Injuries to the wrist and hand

211

1.06

0.09

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1.08

0.09

1.0

—

Mood disorders, excluding more controls

157

0.93

0.08

1.0

1.1

—

Female infertility

0.77

0.08

1.0

—

Seborrhoeic keratosis

1.03

0.08

1.0

—

Myocardial infarction, unclassifiable

0.83

0.08

1.2

1.1

—

Ventral hernia

0.78

0.08

1.2

1.1

—

Benign neoplasm: Colon, unspecified

1.11

0.08

1.1

—

Umbilical hernia

1.06

0.08

1.1

—

Schizophrenia or delusion, excluding more controls

0.84

0.07

1.0

—

Retinal detachments and breaks

1.12

0.07

1.0

1.1

—

Polyp of the female genital tract

1.06

0.07

1.0

—

Malignant neoplasm of breast, HER-positive

0.81

0.07

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.81

0.07

1.0

—

Schizophrenia or delusion

0.80

0.07

1.0

—

Factors influencing health status and contact with health services

1.14

0.07

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.07

0.07

1.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.84

0.07

1.0

—

Primary open-angle glaucoma

1.06

0.07

1.2

1.1

—

Irregular menses

1.13

0.07

1.0

—

Sleep apnoea, including avohilmo

192

0.95

0.06

1.1

1.0

—

Other benign neoplasms of skin

1.01

0.06

1.1

—

Fracture at wrist and hand level

0.87

0.06

1.1

1.0

—

External causes of morbidity and mortality

1.07

0.06

1.0

1.1

—

Shoulder lesions

126

1.07

0.06

1.0

1.1

—

Fall on same level involving ice and snow

148

1.08

0.06

1.0

1.1

—

Inguinal hernia

130

0.93

0.06

1.2

1.0

—

Glucosamine medication

113

0.92

0.06

1.0

1.1

—

Malignant neoplasm of breast

0.90

0.05

1.0

—

Excessive, frequent and irregular menstruation

1.11

0.05

1.0

—

Glaucoma

131

1.07

0.05

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.06

0.04

1.1

—

Alcohol use disorder, Swedish definition

149

1.06

0.03

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative

0.92

0.03

1.0

—

Degeneration of macula and posterior pole

108

1.07

0.03

1.0

—

105

1.07

0.03

1.0

—

Concussion

111

0.94

0.03

1.2

1.0

—

Visual disturbances and blindness

132

1.06

0.02

1.1

1.0

—

Triptan medication for migraine, min. 3 purchases

1.06

0.02

1.2

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

124

0.95

0.01

1.1

1.0

—

Hernia

187

0.98

0.00

1.1

1.0

—

Other and unspecified disorders of vitreous body

106

1.03

0.00

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

117

1.02

0.00

1.0

—

Artificial joint operation, meniscal resection

184

1.01

0.00

1.0

1.1

—

Injuries to the hip and thigh

117

1.02

0.00

1.0

1.1

—

Coxarthrosis, primary, with hip surgery

123

1.00

0.00

1.0

1.1

—

Alcohol use disorder, ICD-based

109

1.01

0.00

1.0

1.1

—

Visual disturbances

121

0.99

0.00

1.1

1.0

—

Allergic conjunctivitis

133

1.04

0.00

1.1

1.0

—

Malignant neoplasm of prostate

1.00

0.00

1.1

—

Sleep apnoea

187

1.02

0.00

1.1

1.0

—

Fracture of lower leg, including ankle

149

1.00

0.00

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

103

0.97

0.00

1.1

—

malignant neoplasm of male genital organs

0.98

0.00

1.1

—

Acute appendicitis, no complications

147

1.02

0.00

1.0

1.1

—

Scissor bite

0.00

0.0

1.0

—

Recurrent dislocation of patella

0.00

0.0

1.0

—

Contact with nonpowered hand tool

0.00

0.0

1.0

—

Acute otitis externa, noninfective

0.00

0.0

1.0

—

Background retinopathy and retinal vascular changes

0.00

0.0

1.0

—

Conduction disorders

0.89

0.00

1.2

1.1

—

Other and unspecified mononeuropathies of lower limb

0.00

0.0

1.0

—

Dermatitis due to ingested food

0.00

0.0

1.0

—

Secondary polycythaemia

0.00

0.0

1.0

—

Alzheimer’s disease (Early onset)

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neutrophil cytoplasmic Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS